RaQualia Pharma Inc.
4579.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥3 | ¥4 | ¥4 | ¥2 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥1 | ¥1 | ¥1 | ¥1 |
| Inventory | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Curr. Assets | ¥5 | ¥5 | ¥5 | ¥4 |
| Property Plant & Equip (Net) | ¥1 | ¥1 | ¥0 | ¥0 |
| Goodwill | ¥4 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥1 | ¥1 | ¥1 | ¥1 |
| Tax Assets | ¥0 | ¥0 | -¥1 | ¥0 |
| Other NC Assets | ¥0 | ¥0 | ¥1 | ¥0 |
| Total NC Assets | ¥5 | ¥2 | ¥1 | ¥1 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥10 | ¥7 | ¥6 | ¥5 |
| Liabilities | – | – | – | – |
| Payables | ¥0 | ¥0 | ¥0 | ¥0 |
| Short-Term Debt | ¥1 | ¥0 | ¥0 | ¥0 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥1 | ¥0 | ¥0 | -¥0 |
| Total Curr. Liab. | ¥1 | ¥0 | ¥0 | ¥0 |
| LT Debt | ¥3 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥0 | ¥0 | ¥0 | ¥0 |
| Total NC Liab. | ¥3 | ¥0 | ¥0 | ¥0 |
| Other Liabilities | ¥0 | -¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥4 | ¥1 | ¥1 | ¥0 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥3 | ¥3 | ¥2 | ¥2 |
| Retained Earnings | -¥0 | ¥0 | ¥1 | ¥0 |
| AOCI | -¥0 | ¥0 | ¥0 | ¥0 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥6 | ¥6 | ¥5 | ¥5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥10 | ¥7 | ¥6 | ¥5 |
| Net Debt | ¥0 | -¥4 | -¥4 | -¥2 |